Success


ViridisChem has the world’s most comprehensive toxicity database with over 90 million chemicals, and utilizing this data, our software tools provide toxicity analysis of chemicals, mixtures and formulations, and product development processes. Learn more about us below.
Featured image for “Webinar 3: Risk Assessment during Green & Sustainable Product Development”
Interviews/Podcasts
January 18, 2022

Webinar 3: Risk Assessment during Green & Sustainable Product Development

Join us on 8th February, 2022 for a discussion about different aspects of green and sustainable product development from risk assessment to support safety and regulatory decisions, to minimizing & mitigating the risks while addressing green chemistry technology scaleup.
Read More
Featured image for “Recent Advances In Avoiding The Use Of PFAS”
Blog
December 10, 2021

Recent Advances In Avoiding The Use Of PFAS

PFAS (Polyfluoroalkyl Substances) are behind a variety of products that we use everyday that make our lives a little bit easier. But US Agency for Toxic Substances and Disease Registry studies have shown that an excess of PFAS can harm our heart, liver, reproductive, and renal systems and lead to cancer.
Read More
Featured image for “Webinar 2: Critical toxicity information for early R&D decisions”
Interviews/Podcasts
October 29, 2021

Webinar 2: Critical toxicity information for early R&D decisions

Presented by ViridisChem, this is a part of Webinar Series “Green Chemistry, what it means today for industry sectors”. Registrations Open
Read More
Featured image for “Webinar1: Green Chemistry, what does it mean today for industry sectors”
Interviews/Podcasts
October 6, 2021

Webinar1: Green Chemistry, what does it mean today for industry sectors

 During this webinar, Dr. Yuanqiao Rao, Fellow at DOW and Dr. David Constable, Technical Director at ACS Green chemistry Institute have shared their decades of experience in guiding companies and communities that have products covering multiple sectors about Green Chemistry adoption, and the level of effort that companies are investing towards green chemistry and sustainable product development.
Read More
Featured image for “Too Many Chemicals, Not Enough Risk Insights – The Perennial Challenge for Scientists”
Blog
October 4, 2021

Too Many Chemicals, Not Enough Risk Insights – The Perennial Challenge for Scientists

There are now more than 100 million chemicals, and thousands of new ones are still being introduced each year. Surprisingly, though, the toxicity is known for less than 1% of chemicals, and many times it is not comprehensive enough.
Read More
Featured image for “Toxicity-focused product development saves time, effort and money”
Interviews/Podcasts
August 31, 2021

Toxicity-focused product development saves time, effort and money

Learn more about the ViridisChem platform and its ability to find less toxic chemicals for your reaction needs to minimize the use of toxic chemicals and minimize toxic waste.
Read More
Featured image for “Understanding health and environmental risks of novel molecules”
Interviews/Podcasts
August 31, 2021

Understanding health and environmental risks of novel molecules

ViridisChem CEO Neelam Vaidya and Technical Advisor Dr. Niteen Vaidya discuss all the factors that are taken into account to predict the toxicity of a new or postulated molecule, and how ViridisChem is approaching the toxicity prediction of novel molecules.
Read More
Featured image for “Challenges in managing health and safety information of millions of chemicals”
Interviews/Podcasts
August 30, 2021

Challenges in managing health and safety information of millions of chemicals

This presentation from ACS Fall 2021 covers the challenges in collecting and curating data from hundreds of sources, in providing comprehensive global regulatory information, GHS classification information.
Read More
Featured image for “Q&A with a Seasoned Chemist on Practicing Green Chemistry”
Blog
August 12, 2021

Q&A with a Seasoned Chemist on Practicing Green Chemistry

We talked with an experienced chemist who has worked as a synthetic medicinal chemist focusing on the drug discovery process. Here are some of the changes he’s seen and his message for peers. (For privacy’s sake, we are not printing his name). By Laurie Kretchmar
Read More